Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2017 Sep 4;19(1):196.
doi: 10.1186/s13075-017-1368-z.

Opportunities and challenges in rheumatology research in Central Europe

Zoltán Szekanecz  1 , Branimir Anic  2 , Gábor Héjj  3 , Iztok Holc  4 , Aniella Hunka  3 , Eugene Kucharz  5 , Klaus Machold  6 , Miroslav Mayer  2 , Artur Pahor  4 , Rudolf Puchner  7 , Jozef Rovensky  8 , Ladislav Senolt  9 , Alena Tuchynova  8 , Jiri Vencovsky  9 , Josef S Smolen  6
Affiliations
Editorial

Opportunities and challenges in rheumatology research in Central Europe

Zoltán Szekanecz et al. Arthritis Res Ther. .

Abstract

The Central European Congress of Rheumatology (CECR) has been organized by seven Central European countries: Austria, Croatia, Czech Republic, Hungary, Poland, Slovakia, and Slovenia. These countries have lots of similarities, but also differences, with respect to rheumatology research. In this paper, based on questionnaires, we wish to demonstrate achievements and difficulties in rheumatology research performed in our region.

Keywords: Arthritis; Central Europe; Collaboration; Funding; Research; Rheumatology.

PubMed Disclaimer

References

    1. Smolen JS, Landewe R, Bijlsma J, Burmester G, Chatzidionysiou K, Dougados M, Nam J, Ramiro S, Voshaar M, van Vollenhoven R, et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update. Ann Rheum Dis. 2017;76(6):960–77. doi: 10.1136/annrheumdis-2016-210715. - DOI - PubMed
    1. Combe B, Landewe R, Daien CI, Hua C, Aletaha D, Alvaro-Gracia JM, Bakkers M, Brodin N, Burmester GR, Codreanu C, et al. 2016 update of the EULAR recommendations for the management of early arthritis. Ann Rheum Dis. 2017;76(6):948–59. doi: 10.1136/annrheumdis-2016-210602. - DOI - PubMed
    1. Muller-Ladner U, Tyndall A, Czirjak L, Denton C, centres E. Matucci-Cerinic M. Ten years EULAR Scleroderma Research and Trials (EUSTAR): what has been achieved? Ann Rheum Dis. 2014;73(2):324–7. doi: 10.1136/annrheumdis-2013-203997. - DOI - PubMed
    1. van Vollenhoven RF, Mosca M, Bertsias G, Isenberg D, Kuhn A, Lerstrom K, Aringer M, Bootsma H, Boumpas D, Bruce IN, et al. Treat-to-target in systemic lupus erythematosus: recommendations from an international task force. Ann Rheum Dis. 2014;73(6):958–67. doi: 10.1136/annrheumdis-2013-205139. - DOI - PubMed
    1. Aggarwal R, Rider LG, Ruperto N, Bayat N, Erman B, Feldman BM, Oddis CV, Amato AA, Chinoy H, Cooper RG, et al. 2016 American College of Rheumatology/European League Against Rheumatism criteria for minimal, moderate, and major clinical response in adult dermatomyositis and polymyositis: An International Myositis Assessment and Clinical Studies Group/Paediatric Rheumatology International Trials Organisation Collaborative Initiative. Ann Rheum Dis. 2017;76(5):792–801. doi: 10.1136/annrheumdis-2017-211400. - DOI - PMC - PubMed

Publication types

LinkOut - more resources